Advertisement
Advertisement

ELOX

ELOX logo

Eloxx Pharmaceuticals, Inc. Common Stock

13.52
USD
Sponsored
+0.88
+6.96%
Jun 12, 16:00 UTC -4
Closed
exchange

After-Market

13.97

+0.46
+3.37%

Eloxx Pharmaceuticals, Inc. Common Stock Profile

About

Eloxx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It engaged in developing novel small molecule medicines to treat many rare and ultra-rare genetic diseases caused by nonsense mutations. The company's lead product candidate consists ELX-02, is an optimized aminoglycoside designed to restore full-length functional proteins. It operates primarily in Waltham, MA and Rehovot, Israel. Eloxx Pharmaceuticals Inc., formerly known as Sevion Therapeutics Inc., is based in WALTHAM, United States.

Info & Links

CEO

Sumit Aggarwal

Headquarters

10 Court Street, P.O. Box 274
ARLINGTON, MA 02476, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.eloxxpharma.com

Auditor

Baker Tilly US, LLP

Share holders

117

Employees

7

Eloxx Pharmaceuticals, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

6.45M

Enterprise Value

77.85K

Enterprise Value/EBITDA(ttm)

-0.01

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

113.62%

Return on Assets(ttm)

--

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-7.19M

Net Income Available to Common(ttm)

-7.35M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

-1.96K

52-Week Change

--

S&P 500 52-Week Change

23.18%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

7.57M

Dividend Yield

0.00%

Float4

0.00

% Held by Insiders

20.20%

% Held by Institutions

2.90%

Balance Sheet

Total Cash(mrq)

6.37M

Total Cash Per Share(mrq)

0.84

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

-16.95%

Current Ratio(mrq)

0.07%

Quick Ratio(mrq)

0.31%

Book Value Per Share(mrq)

-7.19

Cash Flow

Operating Cash Flow Per Share(ytd)

-5.58

Free Cash Flow(ytd)

-14.03M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement